Comparing two ways to diagnose liver injury causes
Part of Digestive system clinical trials.
This study compares two methods (RUCAM and RECAM) to better identify what caused a recent liver injury. It may help doctors find the right cause and treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a sudden liver injury (within the last 3 months) with high liver enzymes or jaundice
- You can provide details about the medication you took before the injury (name, dose, dates)
- Your doctor has determined the cause of the liver injury (like drug reaction, hepatitis, or other conditions listed)
- You do not have liver injury from acetaminophen, mushrooms, chemicals, or past liver/bone marrow transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial builds a prediction model to identify drug-related liver injury (DILI) by looking at your blood test patterns, timing, and expert diagnosis. It may help improve how doctors recognize this condition earlier and more accurately.
This study follows people who developed liver injury from a medicine (not from other causes). It aims to better describe different types and severities of drug-related liver injury and may help improve how clinicians recognize and manage it.
This study puts people with a past drug- or herbal-related liver injury into a research registry. The goal is to better understand why the injury happens so doctors can prevent and recognize it sooner.
This study looks at whether certain genes can predict who is more likely to get liver injury after taking acetaminophen (also found in some cold/flu medicines). By comparing people who were affected with people who were not, it may help doctors identify higher-risk patients in the future.
This trial tests whether steroids (glucocorticoids) can help people with acute liver injury caused by a drug, especially when bilirubin levels are high. It aims to see if steroids can reduce liver damage and improve recovery.
This trial tests whether plasmapheresis (a blood-cleaning procedure) can help people with severe drug-induced liver injury who also have a chronic liver condition. If you qualify, you would receive this treatment to try to reduce liver damage and improve recovery.
Hear when a new Drug Induced Liver Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.